We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LBRX

Price
15.88
Stock movement down
-0.04 (-0.28%)
Company name
LB Pharmaceuticals Inc Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-19

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

LBRX does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash14.22M
Net receivables0.00
Total current assets14.78M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment4.21M
Total assets19.25M
Accounts payable635.00K
Short/Current long term debt3.76M
Total current liabilities3.91M
Total liabilities123.12M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open15.90
Daily high17.08
Daily low15.85
Daily Volume90K
All-time high17.05
1y analyst estimate-
Beta-
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
LBRXS&P500
Current price drop from All-time high-6.89%-3.60%
Highest price drop-12.52%-19.00%
Date of highest drop10 Nov 20258 Apr 2025
Avg drop from high-3.56%-2.72%
Avg time to new high5 days5 days
Max time to new high15 days89 days
COMPANY DETAILS
LBRX (LB Pharmaceuticals Inc Common Stock) company logo
Marketcap
-
Marketcap category
Small-cap
Description
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Employees
16
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner